9
Participants
Start Date
April 1, 2010
Primary Completion Date
March 1, 2011
Study Completion Date
March 1, 2011
Lenalidomide
15 mg orally once daily on Days 1-21 of every 28-day cycle for a maximum of 2 years or until disease progression, unacceptable toxicity develops or voluntary withdrawal.
Placebo
Placebo (identical matched capsule) orally once daily on Days 1-21 of every 28-day cycle for a maximum of 2 years or until disease progression, unacceptable toxicity develops or voluntary withdrawal.
Weill Cornell Medical College/New York Presbyterian Hospital, New York
Fakultni Nemocnice Kralovske Vinohrady, Prague
Azienda Sanitaria Ospedaliera San Giovanni Battista (Molinette), Torino
Arena Oncology Associates, Lake Success
Vseobecna Fakultni Nemocnice, Prague
SUNY Upstate Medical University, Syracuse
Az. Osp. SS.Antonio e Biagio SC Ematologia, Alessandria
"Azienda Ospedaliera Universitaria San Martino", Genova
Fox Chase Cancer Center, Philadelphia
Asklepios Klinik St. Georg - Abteilung für Hämatologie und Stammzelltransplantation, Hamburg
Fondazione San Raffaele del Monte Tabor I.R.C.C.S., Milan
A,O Ospedale Niguarda Ca Granda Dept Hematology, Milan
University of Virginia Health Systems, Charlottesville
Policlinico San Matteo - Dip. Di Ematologia, Pavia
"Università del Piemonte Orientale Amedeo Avogadro", Novara
Hospital Costa del Sol, Oncology, Marbella (Málaga)
Clinica Universitaria de Navarra, Hematology, Pamplona
Hôpital Purpan CHU de Toulouse, Toulouse
Clinica Ematologica - DIRM Azienda Ospedaliera Universitaria, Udine
CHRU - Hôpital du Haut Lévêque, maladies du sang, Centre François Magendie, Pessac
CHU Montpellier - Hôpital Saint Eloi Hématologie et Oncologie Médicale, Montpellier
Hôpital Pontchaillou Hématologie Clinique, Rennes
Hospital Clínico Universitario de Salamanca, Salamanca
Hôpital Bretonneau - CHU Tours, Tours
UKG Universitätsklinikum Göttingen Zentrum Innere Medizin Hämatologie / Onkologie, Göttingen
Centre Hospitalier Lyon Sud, Pavillon Marcel Bérard 1F Hématologie, La Tronche
Hospital Marques de Valdecilla, Santander
Ospedale Regionale di Bolzano - Divisione di Ematologia, Bolzano
CHRU - Hotel Dieu, Nantes
Universitätsklinikum Essen Zentrum für Innere Medizin, Essen
Indiana University Melvin and Bren Simon Cancer Center, Indianapolis
CHU Hôpital Hotel Dieu, Angers
Davidoff Cancer Center The Institute of Hematology, Petah Tikva
Hematology Dept, Azienda Ospedaliero Universitaria Careggi, Florence
CHU de Reims, Hôpital Robert Debré, Hématologie Clinique, Reims
Dolnoslaskie Centrum Transplantacji Komórkowych, Wroclaw
CHU de Nancy Hôpital de Brabois, Service d'Hématologie et Médecine Interne, Vandœuvre-lès-Nancy
Avera Cancer Institute, Sioux Falls
CHRU - Hôpital Claude Huriez, Lille
Rush University Medical Center, Chicago
CHU ESTAING, Service d'Hématologie, Clermont-Ferrand
Nebraska Hematology-Oncology, PC, Lincoln
Centre Hospitalier Lyon Sud, Pavillon Marcel Bérard 1F Hématologie, Pierre-Bénite
IRCCS Casa Sollievo della Sofferenza Div. Di Oncoematologia, S.Giovanni Rotondo (FG)
Universitaetsklinikum Tuebingen, Tübingen
Ospedale Cardinale G. Panico - Ematologia e Immunoematologia, Tricase
Hôpital Saint-Louis, Paris
Centre Henri Becquerel, Rouen
Städtisches Klinikum Karlsruhe - Hämatologie / Onkologie Karlsruhe, Karlsruhe
Fakultni Nemocnice Olomouc, Hemato-Onkologicka Klinika, Olomouc
Universitätsklinikum Freiburg - Medizinische Klinik - Abteilung Innere Medizin I: Hämatologie und Onkologie, Freiburg im Breisgau
CHU Amiens Sud, Centre de Recherche Clinique - Pharmacologie Clinique, Amiens
"Istituto Nazionale Tumori Fondazione G. Pascale - Oncoematologia", Napoli
Rocky Mountain Cancer Center, Denver
Klinikum der Universität München - Großhadern, Medizinische Klinik III, München
Soroka Medical Center The Institute of Hematology, Beersheba
CHD Les Oudairies, Service d'Oncologie Hématologie, La Roche-sur-Yon
CHU de Poitiers, Pôle Régional de Cancérologie, Service d'Oncologie Hématologie et Thérapie Cellulaire, Poitiers
Az. Osp. Bianchi Melacrino Morelli, Div. Di Ematologia, Reggio Calabria
Sharp Healthcare Oncology Associates of San Diego, San Diego
Wojewodzki Szpital Specjalistczny im. Mikolaja Kopernika, Lodz
Hôpital Henri Mondor Unité Hémopathies Lymphoides, Créteil
Providence Cancer Center, Indianapolis
Az. Osp. Ospedali Riuniti Papardo - Piemonte - S.C. Ematologia, Messina
Russian Oncological Research Centre, Moscow
Russian Scientific-research Institute of Hematology and Transfusiology of Federal Medical-biological agency, Saint Petersburg
State Educational Institution of High Professional Education, Saint Petersburg
Federal Center of Heart, Blood and Endocrinology n.a. V.A. Almazov Rosmedtechnologies, Saint Petersburg
"State Healthcare Institution Volgograd Regional Clinical OncologyDispensary #1", Volgograd
Republican Clinical Oncological Dispensary, Kazan'
Perm Regional Clinical Hospital, Perm
Sverdlovsk Regional Clinical Hospital - Volgogradskaya, Yekaterinburg
Hackensack University Medical Center, Hackensack
Fakultni nemocnice Hradec Králové II. Interni klinika-Oddeleni klinicke hematologie, Hradec Králové
Clinic of Oncology Faculty Hospital Motol, Prague
Hospital de Madrid Norte- Sanchinarro, Madrid
C. H. de Orense, Ourense
Università Cattolica del Sacro Cuore Policlinico A. Gemelli, Roma
Małopolskie Centrum Medyczne, Krakow
Serviço de Hematologia, Coimbra
Instituto Português de Oncologia (IPO) de Lisboa, Lisbon
Instituto Português de Oncologia (IPO) do Porto, Porto
Centro de Cancer, Hospital Espanol Auxilio de Puerto Rico, San Juan
Hospital Universitario Vall d´Hebrón Hematology Department, Barcelona
Kent and Canterbury Hospital, Canterbury, Kent
Torbay Hospital, County of Devon
Royal Devon & Exeter Hospital, Exeter
Beatson West of Scotland Cancer Centre, Glasgow
Barts & The London NHS Trust Medical Oncology, London
Derriford Hospital, Plymouth
Salisbury NHS Foundation Trust, Haematology, Salisbury
St Helens Hospital, Lilac Lower Ground, St Helens
Lead Sponsor
Celgene
INDUSTRY